← Leaderboards
Niranjan Sardesai
Viral Genomix, Inc.
$19,016,188
Attributed
$19,016,188
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $6.6M · FY2009–13$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$19,016,188 · 1
By mechanism
N01$19,016,188 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccine Candidate”
- Lawrence Corey · Fred Hutchinson Cancer Center$483,977,044
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$427,604,905
- Barton F Haynes · Duke University$290,267,445
- Kiran Datta · Leidos Biomedical Research, Inc.$277,585,346
- Peter B. Gilbert · Fred Hutchinson Cancer Center$195,104,733
- Wafaa M. El-Sadr · Columbia University Health Sciences$186,594,706
Research focus
Vaccine CandidateClinical TrialsContractorContractsDevicesDna VaccinesElectroporationEvaluationHiv VaccineImmunogenicInnovationPreventiveAids/Hiv Problem
Grant awards (5)
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$1,312,685
N01 · FY2013 · AI · contact PI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$2,529,017
N01 · FY2012 · AI · contact PI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$3,342,566
N01 · FY2011 · AI · contact PI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$5,258,144
N01 · FY2010 · AI · contact PI
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV$6,573,776
N01 · FY2009 · AI · contact PI